stockrow
Friday 6 November 2026
Export ACON’s income statement to Excel — free account
Aclarion, Inc.
ACON Healthcare Health Information Services
Aclarion, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75,700.00, up 65.6% from fiscal 2024.
- Revenue
- +78.5%
- EPS
- +67.9%
- Free cash flow
- −74.2%
Quarter to September 2026, against a year earlier
1.66
0.10
+6.41%
Follow ACON
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 4 | 4 | 5 |
+8 more TTM periods Free account |
| (74.07%) | (58.97%) | (45.43%) | (104.89%) | ||
| (69.66%) | (56.09%) | (43.37%) | (91.67%) | ||
ROIC |
(1,120.88%) | (876.79%) | (855.42%) | (554.92%) | |
Return on Tangible Assets |
(74.51%) | (58.28%) | (43.72%) | (62.50%) | |
Average Days of Receivables |
123.14 | 122.97 | 190.48 | 143.20 | |
Free Cash Flow per Share |
(3.29) | (3.36) | (3.50) | (13.86) | |
Free Cash Flow |
(9.14) | (8.26) | (7.45) | (7.37) | |
Capital Expenditures |
(0.19) | (0.17) | (0.15) | (0.21) | |
| Other line items | |||||
Cash ROIC |
(31.49%) | (24.80%) | (19.25%) | (29.64%) | |
Accounts Receivable Turnover |
3.02 | 3.41 | 2.60 | 3.15 | |
Accounts Payable Turnover |
0.27 | 0.13 | 0.11 | 0.16 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
1,234.85 | 3,922.64 | 3,408.02 | 1,761.52 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
1,265.68% | 1,406.93% | 1,479.31% | 1,365.52% | |
Selling, General and Administrative Expense of Revenue |
9,555.56% | 10,216.49% | 9,526.35% | 7,959.58% | |
Share Based Compensation of Revenue |
544.00% | 152.81% | 69.67% | 139.23% | |
Operating CF/Net income |
0.88 | 0.88 | 0.91 | 0.99 | |
Depreciation/Fixed assets |
0.00 | 10.45 | 10.18 | 9.40 | |
Capex/Depreciation |
0.00 | (0.72) | (0.66) | (0.92) | |
Revenue per Share |
0.04 | 0.03 | 0.04 | 0.14 | |
Operating CF per Share |
(3.22) | (3.28) | (3.43) | (13.47) | |
Capex per Share |
(0.07) | (0.07) | (0.07) | (0.39) | |
Capex to Sales |
1.94 | 2.09 | 1.97 | 2.76 |
Columns are period end dates · fundamentals updated 5 Nov 2026